SCHEMBL18019941

SCHEMBL18019941

O=c1c2cc3c(cc2n(-c2cc(-c4ccccc4)cc(-c4ccccc4)c2)c(=O)n1-c1cc(-c2ccccc2)cc(-c2ccccc2)c1)c1ccccc1n3-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
ATM Q13315 1/20 0.47
KMT2A Q03164 6/20 0.47
PGR P06401 4/20 0.47
MAPK8 P45983 3/20 0.44
MAPK9 P45984 2/20 0.43
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 3/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
BRCA1 P38398 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18019946 0.97 KMT2A (0.43) KDM4EL3MBTL1ATMKMT2APGR
SCHEMBL18019940 0.92 ATM (0.47) KDM4EL3MBTL1ATMKMT2APGR
SCHEMBL18019942 0.90 KDM4E (0.58) KDM4EL3MBTL1ATMKMT2APGR
SCHEMBL18020166 0.90 PGR (0.48) KDM4EL3MBTL1ATMKMT2APGR
SCHEMBL14933364 0.89 KMT2A (0.52) KDM4EL3MBTL1ATMKMT2APGR
SCHEMBL18020167 0.89 PGR (0.47) KDM4EL3MBTL1ATMKMT2APGR
SCHEMBL15988942 0.87 L3MBTL1 (0.62) KDM4EL3MBTL1ATMKMT2APGR
SCHEMBL19844355 0.86 PGR (0.51) KDM4EL3MBTL1ATMKMT2APGR
SCHEMBL17019445 0.86 L3MBTL1 (0.60) KDM4EL3MBTL1ATMKMT2APGR
SCHEMBL18019987 0.85 KDM4E (0.49) KDM4EL3MBTL1ATMKMT2APGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10249831-B2 Electronic device containing cyclic lactams MERCK PATENT GMBH (DE) 2019-04-02 US disclosed
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2018-02-08 US disclosed
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2018-02-08 US disclosed
WO-2016128103-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2016-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10249831-B2 Electronic device containing cyclic lactams OXA1L, UROD, MRPL21 KDM4E 2116/4885L3MBTL1 3138/4885ATM 3206/4885
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS OXA1L, UROD, MRPL21 KDM4E 2116/4885L3MBTL1 3138/4885ATM 3206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.